BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

This publication has 35 references indexed in Scilit:

• Réseau RENAPE : vers une nouvelle organisation des soins pour le traitement des tumeurs rares du péritoine. Description du réseau et rôle des pathologistes
  Annales de Pathologie, 2014
• Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
  Proceedings of the National Academy of Sciences, 2013
• BAP1 is phosphorylated at serine 592 in S‐phase following DNA damage
  FEBS Letters, 2013
• BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma
  Pathology and Oncology Research, 2013
• Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group
  Archives of Pathology & Laboratory Medicine, 2013
• Germline BAP1 mutations predispose to malignant mesothelioma
  Nature Genetics, 2011
• The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
  Nature Genetics, 2011
• An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression
  Cell Biochemistry and Biophysics, 2011
• BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization
  Cancer Research, 2008
• Mutation and Cancer: Statistical Study of Retinoblastoma
  Proceedings of the National Academy of Sciences, 1971